366 related articles for article (PubMed ID: 8416554)
1. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
2. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
Mahfouz AE; Hamm B; Wolf KJ
Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
[TBL] [Abstract][Full Text] [Related]
3. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
4. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
5. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of focal nodular hyperplasia of the liver: value of contrast-enhanced dynamic study.
Irie H; Honda H; Kaneko K; Kuroiwa T; Fukuya T; Yoshimitsu K; Ono M; Kawanami T; Yoshida M; Maeda T; Masuda K
Radiat Med; 1997; 15(1):29-35. PubMed ID: 9134582
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas.
Hamed MM; Hamm B; Ibrahim ME; Taupitz M; Mahfouz AE
AJR Am J Roentgenol; 1992 Feb; 158(2):303-7. PubMed ID: 1729787
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging.
Yamashita Y; Hatanaka Y; Yamamoto H; Arakawa A; Matsukawa T; Miyazaki T; Takahashi M
Radiology; 1994 Oct; 193(1):59-65. PubMed ID: 8090922
[TBL] [Abstract][Full Text] [Related]
12. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
14. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
[TBL] [Abstract][Full Text] [Related]
16. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
17. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
18. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.
Grazioli L; Morana G; Federle MP; Brancatelli G; Testoni M; Kirchin MA; Menni K; Olivetti L; Nicoli N; Procacci C
Radiology; 2001 Dec; 221(3):731-9. PubMed ID: 11719669
[TBL] [Abstract][Full Text] [Related]
19. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Guthrie JA; Ward J; Robinson PJ
Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
